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Summary
Beta-human chorionic gonadotropin (βhCG) is normally produced by syncytiotrophoblasts of the placenta during 
pregnancy and aids embryo implantation. However, it is also secreted in varying amounts in non-pregnant conditions 
commonly heralding a neoplastic process. We present a case of 50-year-old man, who presented with bilateral 
gynaecomastia with elevated testosterone, oestradiol, suppressed gonadotropins with progressively increasing levels of 
human chorionic gonadotropin (hCG). Biochemical and radiological investigations including ultrasonography of testes, 
breast tissue, MRI pituitary and CT scan full body did not identify the source of hCG. FDG PET scan revealed a large 
mediastinalmasswithlungmetastasis.Immunostainingandhistologicalanalysisconfirmedthediagnosisofprimary
choriocarcinoma of the mediastinum. It is highly aggressive and malignant tumor with poor prognosis. Early diagnosis and 
management are essential for the best outcome.
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Learning points:
•• High βhCG in a male patient or a non-pregnant female suggests a paraneoplastic syndrome.
•• In the case of persistently positive serum hCG, exclude immunoassay interference by doing the urine hCG as 
heterophilic antibodies are not present in the urine.
•• Non-gestational choriocarcinoma is an extremely rare trophoblastic tumor and should be considered in young 
men presenting with gynaecomastia and high concentration of hCG with normal gonads.
•• A high index of suspicion and extensive investigations are required to establish an early diagnosis of extra-gonadal 
choriocarcinoma.
•• Early diagnosis is crucial to formulate optimal management strategy and to minimize widespread metastasis for 
best clinical outcome.
Background
The case describes a presentation of a rare disease. It 
highlights an unexpected association between symptoms 
and disease in a male. It is a challenging diagnosis and 
requires a high index of suspicion.
Case presentation
A 50-year-old man was referred to the endocrine clinic 
with 3 months of history painful bilateral gynaecomastia. 
He was due to have a hip replacement. He was otherwise 
fit and well and worked as a physical trainer in the 
Metropolitan Police department. He had no history of 
any discharge from the nipples and had never used any 
illicit drugs. In his past medical history, he reported 
an episode of left breast lump nine years ago. This was 
investigated with an ultrasound scan and fine-needle 
aspiration (FNA). FNA confirmed normal breast tissue, 
and he was treated with tamoxifen with the resolution 
of the lump. He was not on any regular medications at 
the time of this presentation. He was a non-smoker and 
did not drink alcohol. He had a BMI of 26 kg/m2. He had 
moderate bilateral gynaecomastia with no discrete lumps. 
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His testicular examination was normal with bilaterally 
descended firm testes measuring 20 mL. He had no 
lymphadenopathy and systemic examination was normal.
Investigation
His full blood count, renal function tests and liver function 
tests (LFTs) were normal. Data are presented in Table 1. 
The laboratory data at presentation, FSH and LH were 
undetectable. Total testosterone level was high with high 
oestradiol. Sex hormone binding globulin (SHBG) levels 
were normal. Alpha fetoprotein was within normal range. 
Human chorionic gonadotrophin (HCG) was very high. 
Urine test was also positive for HCG thus excluding the 
possibility of heterophile antibody interference with serum 
HCG assay. Table 2 presents serial measurement of FSH, LH, 
testosterone and oestradiol over 3 months showing persistent 
suppression of gonadotrophins with high testosterone and 
oestradiol. Figure 1 shows rapidly increasing hCG levels 
in the 4 months prior to treatment. Positron emission 
tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose 
integrated with computed tomography (18F-FDG PET/
CT) revealed a large lesion in the anterior mediastinum 
with metastatic deposit in the lung (Fig. 2). The data in 
table 3 shows normalization of FSH, LH amd testosterone 
with undetectable hCG after completion of treatment.
Treatment
CT guided biopsy was attempted without success. Open 
mediastinotomy was subsequently undertaken and 
adequate sample of mediastinal lesion was obtained for 
histology and immunostaining. Histological examination 
confirmed the diagnosis of primary non-gestational 
choriocarcinoma (Fig. 3).
Outcome and follow-up
Patient was treated with POMB/ACE (cisplatin, 
vincristine, methotrexate, bleomycin, actinomycin, 
cyclophosphamide and etoposide) followed by TP/TE 
(paclitaxel/cisplatin alternating with paclitaxel/etoposide). 
He then had surgery to remove primary and pulmonary 
metastasis. Histology showed only dead tissue and no active 
cancer 3 years after the diagnosis and treatment patient is 
in remission. He ran the London marathon this year.
Discussion
Choriocarcinoma is an aggressive germ cell tumor. It is 
categorized into two types: (1) gestational choriocarcinoma, 
also termed as secondary choriocarcinoma diagnosed in 
the context of pregnancy which occurs in association 
with hydatiform mole (50%), abortion (30%) and normal 
pregnancy (20%), (2) Non gestational choriocarcinoma, 
also called primary choriocarcinoma which is diagnosed 
in post-menopausal women and in men as non-
seminomatous testicular tumor (1). The principal site of 
primary choriocarcinoma is gonads in both sexes, extra-
gonadal origin of primary choriocarcinomas including 
peritoneal organs, retroperitoneum and mediastinum have 
been reported (2). Mediastinal origin of choriocarcinoma 
is rare with only 50 cases reported in the literature, almost 
all in men. These are usually diagnosed during the second 
to third decade of life (3). These tumours are highly 
malignant and tend to metastasize rapidly, most commonly 
to lungs. Histologically, two types of cells are observed, 
syncytiotrophoblasts and cytotrophoblasts in association 
with extensive haemorrhage and necrosis. Immune studies 
confirm staining for beta human chorionic gonadotropin 
Table 1 Laboratory data.
Test Value Range
FT4 13.9 12–22 pmol/L
TSH 1.06 0.27–4.20 mU/L
Prolactin 409 86–324 mU/L
IGF-1 22.4 5.6–29.5 nmol/L
α fetoprotein 4 0–10 kU/L
PSA 1 0.0–3.0 µg/L
FSH <0.1 2–10 IU/L
LH <0.1 2–9 IU/L
Testosterone 26.2 6.68–25.70 nmol/L
SHBG 37 20.6–76.7 nmol/L
Oestradiol 298 99–192 pmol/L
HCG 250 0–2 IU/L
FSH, follicular-stimulating hormone; HCG, human chorionic gonadotropin; 
IGF-1, insulin-like growth factor; LH, luteinising hormone; PSA, prostate-
specificantigen;SHBG,sexhormone-bindingglobulin.
Table 2 Serial testosterone and oestradiol.
Date FSH (2–10 IU/L) LH (2–9 IU/L) SHBG (20.6–76.7 nmol/L)
 
Testosterone (6.6–25.7 nmol/L) Oestradiol (99–192 pmol/L)
18.4.16 <0.1 <0.1 44 36.2 354
2.6.16 <0.1 <0.1 37 30.7 298
11.7.16 <0.1 <0.1 33 33.4 417
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(hCG) which is secreted in excessive amounts and usually 
serves as a key marker for diagnosis as in our patient (Fig. 1). 
It is also utilized as a prognostic marker and to monitor 
response to treatment. The origin of the tumor is uncertain. 
One explanation is the testicular origin with metastasis 
to the mediastinum and subsequent involution and 
regression of primary testicular tumor before the diagnosis 
(4, 5). It is, however, challenged by the fact that testicular 
tumors usually metastasize to retroperitoneal nodes 
initially, bypassing mediastinum. Another widely accepted 
explanation is entrapment of germ cells arising from the 
mesothelium of primitive gonads or yolk sac endoderm 
along the urogenital ridge which remains dormant and only 
manifests in malignant form by stimulation after puberty (6, 
7). Detailed and extensive search for primary origin should 
be conducted with the main focus on gonads before making 
a diagnosis of primary mediastinal choriocarcinoma. The 
classic triad of chest pain, cough and fever is described 
in the literature but may not be the presenting feature of 
mediastinal choriocarcinoma as in our case. He presented 
with gynaecomastia due to high circulating levels of human 
chorionic gonadotropin produced by the tumor. Human 
chorionic gonadotropins (hCG) is heterodimeric belonging 
to hormone family of glycoproteins and share alpha subunit 
with LH, FSH, and TSH. Besides, its beta subunit has closer 
homology with LH and therefore it may act as LH analogue 
which is exploited in the treatment of hypogonadism and 
infertility by using synthetic or purified hCG in stimulating 
testosterone secretion and inducing spermatogenesis. 
Figure 1
Graph: Increasing HCG level.
Figure 2
18F-FDG PET/CT: Image 1 and Image 2: Increased tracer uptake in anterior 
Mediastinum. Image 3: Increased tracer uptake left lung suggesting 
metastasis.
Figure 3
Histology. (A) Gross specimen. (B) Bi-phasic population cytotrophoblast/
syncytiotrophoblast cell populations of the human placenta. (C) 
Numerousmitoticfigures.(D)Positivecytokeratinimmunostain.(E)
Positive placental alkaline phosphatase. (F) Positive® hCG staining.
Table 3 Post treatment data.
Test Value Range
α fetoprotein 3 0–10 kU/L
PSA 1 0.0–3.0 µg/L
FSH 18 2–10 IU/L
LH 7 2–9 IU/L
Testosterone 10 6.68–25.70 nmol/L
Oestradiol 93 99–192 pmol/L
HCG 0.5 0–2 IU/L
FSH, follicular-stimulating hormone; HCG, human chorionic gonadotropin; 
LH,luteinisinghormone;PSA,prostate-specificantigen.
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In our case, elevated levels of hCG stimulated testosterone 
secretion to supraphysiological levels which in turn was 
aromatized to oestradiol thus causing gynaecomastia. A high 
concentration of oestradiol and testosterone reduced the 
secretion of pituitary gonadotropins via negative feedback 
fashion. Mediastinal choriocarcinoma is associated with 
poor prognosis and carries a high risk of recurrence (8). It can 
involve surrounding mediastinal structures and lungs and can 
also rarely spread to liver, spleen, kidneys and gastrointestinal 
tract (9). Early diagnosis and timely management involving 
surgical, radiological and chemotherapeutic strategies is 
essential for best outcome (10).
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